Related Experiment Video
Updated: Jun 22, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
[Bone loss owing to inflammatory bowel disease: prospective study, 50 cases]
Kaouther Saadallaoui Ben Hamida1, Meriem Serghini, Iméne Ksontini
1Service de Médecine Interne, Hôpital des Forces de sécuritée Intérieure. 2070 La Marsa.
Inflammatory bowel disease (IBD) patients have a high prevalence of osteoporosis. Age over 35, disease duration over 10 years, and intestinal resection are key risk factors for osteoporosis in IBD.
Area of Science:
- Gastroenterology and Endocrinology
- Bone Metabolism Research
Context:
- Inflammatory bowel disease (IBD) is associated with significant systemic complications.
- Osteoporosis is a common comorbidity in IBD patients, impacting bone health.
- Understanding osteoporosis prevalence and risk factors in IBD is crucial for patient management.
Purpose:
- To determine the prevalence of osteoporosis in patients with inflammatory bowel disease (IBD).
- To identify specific risk factors contributing to osteoporosis development in IBD patients.
Summary:
- A prospective study of 50 IBD patients (30 Crohn's disease, 20 ulcerative colitis) revealed a 45% prevalence of low bone mineral density (13% osteoporosis, 32% osteopenia).
- Key risk factors identified include age over 35, disease duration exceeding 10 years, and history of intestinal resection.
- Factors such as sex, IBD type, malnutrition, and corticosteroid use were not found to be significant risk factors in this cohort.
Impact:
- Highlights the high incidence of osteoporosis in IBD, necessitating routine screening.
- Provides evidence for targeted interventions in IBD patients with identified risk factors.
- Emphasizes the importance of early detection and treatment to mitigate bone loss and fractures in IBD.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease

